Friday 6 November 2026
Export WAY’s income statement to Excel — free account
Waystar Holding Corp.
WAY Healthcare Health Information Services
Waystar Holding Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.1 billion, up 16.5% from fiscal 2024.
- Revenue
- +21.2%
- EPS
- −10.2%
- Free cash flow
- +23.4%
- Total debt
- +18.4%
Quarter to September 2026, against a year earlier
28.33
0.55
−1.90%
Follow WAY
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
51.17 | 34.44 | 28.51 | 36.12 |
P/S ratio |
5.30 | 4.00 | 3.27 | 3.85 | |
P/FCF ratio |
20.58 | 15.72 | 16.00 | 18.42 | |
P/Operating CF |
87.45 | 54.42 | 66.30 | 46.83 | |
P/B ratio |
1.50 | 1.17 | 0.99 | 1.20 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
6.55 | 5.10 | 4.30 | 4.77 | |
EV/EBITDA |
18.34 | 14.20 | 11.91 | 13.56 | |
EV/Operating CF |
23.24 | 17.87 | 17.68 | 19.14 | |
EV/FCF |
25.42 | 20.08 | 21.04 | 22.82 | |
Quick Ratio |
1.31 | 1.64 | 1.73 | 1.99 | |
Current Ratio |
1.41 | 1.76 | 1.85 | 2.10 | |
Net Debt/EBITDA |
13.69 | 10.46 | 10.51 | 11.24 | |
Debt/Assets |
25.46% | 25.17% | 24.99% | 24.71% | |
Debt/Equity |
0.38 | 0.37 | 0.37 | 0.36 | |
Asset Turnover |
0.21 | 0.22 | 0.23 | 0.24 | |
Operating CF/Net income |
3.33 | 1.96 | 1.45 | 3.35 | |
Capex/Depreciation |
(0.23) | (0.36) | (0.38) | (0.24) | |
Interest Coverage |
2.58 | 3.90 | 3.87 | 3.17 | |
Research and Development Expense of Revenue |
6.10% | 5.85% | 5.54% | 6.23% | |
Selling, General and Administrative Expense of Revenue |
30.61% | 24.39% | 27.14% | 31.75% | |
Intangible Assets out of Total Assets |
0.92 | 0.90 | 0.89 | 0.88 | |
Share Based Compensation of Revenue |
4.02% | 3.65% | 4.32% | 7.51% | |
Graham Net Nets |
(0.27) | (0.33) | (0.37) | (0.28) | |
Graham Number |
17.72 | 17.99 | 18.35 | 18.22 | |
Earnings Yield |
1.95% | 2.90% | 3.51% | 2.77% | |
Free Cash Flow Yield |
4.86% | 6.36% | 6.25% | 5.43% | |
Revenue per Share |
1.71 | 1.64 | 1.67 | 1.70 | |
Operating CF per Share |
0.37 | 0.44 | 0.31 | 0.54 | |
Capex per Share |
(0.05) | (0.08) | (0.08) | (0.05) | |
Free Cash Flow per Share |
0.32 | 0.36 | 0.23 | 0.49 | |
Cash per Share |
0.57 | 0.98 | 1.17 | 1.57 | |
Shareholders Equity per Share |
21.80 | 20.54 | 20.78 | 21.03 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
21.80 | 20.54 | 20.78 | 21.03 | |
Free Cash Flow |
57.22 | 69.59 | 43.30 | 93.94 | |
Working Capital |
90.35 | 166.65 | 201.25 | 270.28 | |
Capital Expenditures |
(9.41) | (15.33) | (16.11) | (9.92) | |
Net Current Asset Value |
(1,597.86) | (1,514.94) | (1,443.54) | (1,370.80) | |
EV/EBIT |
28.87 | 22.31 | 18.79 | 21.77 | |
Capex to Sales |
0.03 | 0.05 | 0.05 | 0.03 | |
Price to Operating Income |
23.37 | 17.47 | 14.28 | 17.57 | |
| Other line items | |||||
Average Receivables |
165.77 | 159.90 | 164.69 | 166.34 | |
Average Payables |
49.16 | 51.93 | 51.48 | 59.74 | |
Average Assets |
5,181.05 | 5,229.09 | 5,273.34 | 5,334.60 | |
Average Common Equity |
3,479.31 | 3,531.68 | 3,579.69 | 3,629.59 |
Columns are period end dates · fundamentals updated 5 Nov 2026